cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.5993271
title: Dataset related to article "Re-irradiation for recurrent high grade glioma (HGG) patients: Results of a single arm prospective phase 2 study"

description: This record contains raw data related to article “Re-irradiation for recurrent high grade glioma (HGG) patients: Results of a single arm prospective phase 2 study" <strong>Background and purpose: </strong> Standard of care for recurrent high grade glioma (HGG) is missing. Several treatment options have been investigated including re-irradiation (re-RT). Results are promising but provided by retrospective studies. We designed a single arm prospective phase II study aiming to evaluate efficacy, and toxicity of re-irradiation. <strong>Materials and methods: </strong> Adults patients with good performance status, HGG diagnosis reclassified according to the new 2021 fifth edition WHO CNS classification, an interval time (IT) from previous RT ≥ 6 months were included. Outcome was evaluated by MRI imaging at 1 month, and every 3 months thereafter. Toxicities were evaluated in terms of radionecrosis occurrence, and neurocognitive status. <strong>Results: </strong> Ninety recurrent HGG patients were treated, 11 oligodendroglioma grade 3, 18 astrocytoma grade 3 and 4, and 61 glioblastoma grade 4. The median age was 54 years, and majority had KPS 90-100. The median IT between first-RT and re-RT was 24 months. Re-surgery has been performed in 56.6%, and chemotherapy in 53.3%. The median follow up time was 64 months; median overall survival (OS) time,1,2,3-year OS rates were 17 months (95%CI 14-19), 66.7%±4.9, 32.6%±5.0, and 22.2 ± 4.7. Prognostic factors impacting on survival were age (p = 0.0154), IT between first RT and re-RT (p = 0.0051), glioma grade (p = 0.0090), and IDH status (p = 0.0001). Radionecrosis grade 2-3 occurred in 9 (10%) patients; neurocognitive functions remained stable until disease progression. <strong>Conclusion: </strong> Re-RT proved to be a safe and feasible treatment option with low toxicity. Younger patients with grade 3 IDH mutated gliomas, and a longer IT had the better outcome.
DOI: 10.5517/ccdc.csd.cc20k9tq
title: CCDC 1863683: Experimental Crystal Structure Determination

description: Related Article: Inho Choi,  Sanghee Yang,  Tae-Lim Choi|2018|J.Am.Chem.Soc.|140|17218|doi:10.1021/jacs.8b10406
description: Related Article: Inho Choi|2018|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27qrvl
title: CCDC 2077460: Experimental Crystal Structure Determination

description: Related Article: Ming Gong, Mengmeng Huang, Yabo Li, Jianye Zhang, Jung Keun Kim, Jong Seung Kim, Yangjie Wu|2022|Green Chemistry|24|837|doi:10.1039/D1GC03587H
DOI: 10.5517/ccdc.csd.cc27qrzq
title: CCDC 2077464: Experimental Crystal Structure Determination

description: Related Article: Ming Gong, Mengmeng Huang, Yabo Li, Jianye Zhang, Jung Keun Kim, Jong Seung Kim, Yangjie Wu|2022|Green Chemistry|24|837|doi:10.1039/D1GC03587H
DOI: 10.5517/ccdc.csd.cc27qs0s
title: CCDC 2077465: Experimental Crystal Structure Determination

description: Related Article: Ming Gong, Mengmeng Huang, Yabo Li, Jianye Zhang, Jung Keun Kim, Jong Seung Kim, Yangjie Wu|2022|Green Chemistry|24|837|doi:10.1039/D1GC03587H
DOI: 10.5517/ccdc.csd.cc28r1hl
title: CCDC 2107519: Experimental Crystal Structure Determination

description: Related Article: Jing Liu, Ziang Chen, Jia Hu, Hongxia Sun, Yan Liu, Zhongyi Liu, Jinpeng Li|2022|Inorg.Chem.Front.|9|584|doi:10.1039/D1QI01435H
DOI: 10.5517/ccdc.csd.cc28r1jm
title: CCDC 2107520: Experimental Crystal Structure Determination

description: Related Article: Jing Liu, Ziang Chen, Jia Hu, Hongxia Sun, Yan Liu, Zhongyi Liu, Jinpeng Li|2022|Inorg.Chem.Front.|9|584|doi:10.1039/D1QI01435H
DOI: 10.5517/ccdc.csd.cc20p3xr
title: CCDC 1867344: Experimental Crystal Structure Determination

description: Related Article: Manickam Bakthadoss, Tadiparthi Thirupathi Reddy, Vishal Agarwal, Duddu S. Sharada|2022|Chem.Commun.|58|1406|doi:10.1039/D1CC06097J
DOI: 10.5281/zenodo.5993127
title: Dataset related to article "Is Anti-Müllerian Hormone a Marker of Ovarian Reserve in Young Breast Cancer Patients Receiving a GnRH Analog during Chemotherapy?"

description: This record contains raw data related to article “Is Anti-Müllerian Hormone a Marker of Ovarian Reserve in Young Breast Cancer Patients Receiving a GnRH Analog during Chemotherapy?" <strong><em>Introduction:</em></strong> Anti-Müllerian hormone (AMH) is the most reliable biomarker of ovarian reserve; however, its role in predicting ovarian recovery after chemotherapy is unclear. Administration of a GnRH analog (GnRHa) during chemotherapy significantly reduces the ovarian failure rate and increases the pregnancy rate. The available data on the behavior of AMH during concurrent administration of chemotherapy and GnRHa are inconsistent. We investigated whether concurrent administration of triptorelin and adjuvant chemotherapy might reduce the expected drop of AMH. <strong><em>Methods:</em></strong> Eligible patients were premenopausal women aged &lt;40 years, with a diagnosis of early breast cancer, and candidates to 4–8 cycles of adjuvant chemotherapy. Triptorelin (3.75 mg i.m.) was started before chemotherapy and administered every 4 weeks thereafter. The principal endpoint was the proportion of patients with an AMH percent change ≤50% between 12 months after chemotherapy and basal levels. The secondary endpoint was the proportion of patients achieving postchemotherapy AMH levels above the threshold of 0.2 ng/mL. <strong><em>Results:</em></strong> Fifty patients were enrolled, 31 of whom had blood samples available at baseline and 1 year after the end of chemotherapy. AMH decreased to nearly undetectable levels after chemotherapy and recovered after 12 months, but they did not exceed 1 tenth of the pretreatment levels. As for the secondary endpoint, 15 of the 31 patients recovered AMH levels above the threshold. <strong><em>Conclusions:</em></strong> This study did not reach its principal endpoint; however, the rate of 48% of patients who recovered AMH above threshold levels favorably compared with those in studies without concurrent GnRHa, supporting a better recovery of AMH with triptorelin.
DOI: 10.5281/zenodo.5993126
title: Dataset related to article "Is Anti-Müllerian Hormone a Marker of Ovarian Reserve in Young Breast Cancer Patients Receiving a GnRH Analog during Chemotherapy?"

description: This record contains raw data related to article “Is Anti-Müllerian Hormone a Marker of Ovarian Reserve in Young Breast Cancer Patients Receiving a GnRH Analog during Chemotherapy?" <strong><em>Introduction:</em></strong> Anti-Müllerian hormone (AMH) is the most reliable biomarker of ovarian reserve; however, its role in predicting ovarian recovery after chemotherapy is unclear. Administration of a GnRH analog (GnRHa) during chemotherapy significantly reduces the ovarian failure rate and increases the pregnancy rate. The available data on the behavior of AMH during concurrent administration of chemotherapy and GnRHa are inconsistent. We investigated whether concurrent administration of triptorelin and adjuvant chemotherapy might reduce the expected drop of AMH. <strong><em>Methods:</em></strong> Eligible patients were premenopausal women aged &lt;40 years, with a diagnosis of early breast cancer, and candidates to 4–8 cycles of adjuvant chemotherapy. Triptorelin (3.75 mg i.m.) was started before chemotherapy and administered every 4 weeks thereafter. The principal endpoint was the proportion of patients with an AMH percent change ≤50% between 12 months after chemotherapy and basal levels. The secondary endpoint was the proportion of patients achieving postchemotherapy AMH levels above the threshold of 0.2 ng/mL. <strong><em>Results:</em></strong> Fifty patients were enrolled, 31 of whom had blood samples available at baseline and 1 year after the end of chemotherapy. AMH decreased to nearly undetectable levels after chemotherapy and recovered after 12 months, but they did not exceed 1 tenth of the pretreatment levels. As for the secondary endpoint, 15 of the 31 patients recovered AMH levels above the threshold. <strong><em>Conclusions:</em></strong> This study did not reach its principal endpoint; however, the rate of 48% of patients who recovered AMH above threshold levels favorably compared with those in studies without concurrent GnRHa, supporting a better recovery of AMH with triptorelin.
DOI: 10.6084/m9.figshare.19130354
title: Faustian Bargain

description: The data analysis file could be accessed here
DOI: 10.6084/m9.figshare.19130354.v1
title: Faustian Bargain

description: The data analysis file could be accessed here
DOI: 10.48370/ofd/ezvjz5/qpggjr
title: Peronospora sordida Berkeley & Broome F-2435.tif

description: :unav
DOI: 10.48370/ofd/ezvjz5
title: Peronospora sordida Berkeley Broome, 2435

description: Fungarium Micromycetes
DOI: 10.48370/ofd/ienwsv/bg8xet
title: Peronospora sordida Berkeley & Broome F-3822.tif

description: :unav
DOI: 10.48370/ofd/ienwsv
title: Peronospora sordida Berkeley Broome, 3822

description: Fungarium Micromycetes
DOI: 10.48370/ofd/woayl4/jyqb49
title: Peronospora sordida Berkeley & Broome F-1301.tif

description: :unav
DOI: 10.48370/ofd/woayl4
title: Peronospora sordida Berkeley Broome, 1301

description: Fungarium Micromycetes
DOI: 10.48370/ofd/bvgn48/jkrwag
title: Peronospora sordida Berkeley & Broome F-2799 (2).tif

description: :unav
DOI: 10.48370/ofd/bvgn48/o70p9g
title: Peronospora sordida Berkeley & Broome F-2799 (5).tif

description: :unav
DOI: 10.48370/ofd/bvgn48/sczxos
title: Peronospora sordida Berkeley & Broome F-2799 (4).tif

description: :unav
DOI: 10.48370/ofd/bvgn48/jm0gvy
title: Peronospora sordida Berkeley & Broome F-2799.tif

description: :unav
DOI: 10.48370/ofd/bvgn48/ujddbz
title: Peronospora sordida Berkeley & Broome F-2799 (3).tif

description: :unav
DOI: 10.48370/ofd/bvgn48
title: Peronospora sordida Berkeley Broome, 2799

description: Fungarium Micromycetes
DOI: 10.48370/ofd/nucjge/tdtfml
title: Peronospora stachydis H. Sydow F-1111.tif

description: :unav
DOI: 10.48370/ofd/nucjge
title: Peronospora stachydis H. Sydow, 1111

description: Fungarium Micromycetes
DOI: 10.48370/ofd/fc2ome/dovkfs
title: Peronospora stachydis H. Sydow F-0057.tif

description: :unav
DOI: 10.48370/ofd/fc2ome
title: Peronospora stachydis H. Sydow, 57

description: Fungarium Micromycetes
DOI: 10.48370/ofd/2vw2kp/bwkxqq
title: Peronospora stachydis H. Sydow F-1505.tif

description: :unav
DOI: 10.48370/ofd/2vw2kp
title: Peronospora stachydis H. Sydow, 1505

description: Fungarium Micromycetes
DOI: 10.48370/ofd/3bc4em/bdhhi1
title: Peronospora trifoliorum de Bary F-4301.tif

description: :unav
DOI: 10.48370/ofd/3bc4em
title: Peronospora trifoliorum de Bary, 4301

description: Fungarium Micromycetes
DOI: 10.48370/ofd/gdtyl8/gpwlie
title: Peronospora trifoliorum de Bary F-0188.tif

description: :unav
DOI: 10.48370/ofd/gdtyl8
title: Peronospora trifoliorum de Bary, 188

description: Fungarium Micromycetes
DOI: 10.48370/ofd/jxwcvz/x3t2um
title: Peronospora trifoliorum de Bary F-0187.tif

description: :unav
DOI: 10.48370/ofd/jxwcvz
title: Peronospora trifoliorum de Bary, 187

description: Fungarium Micromycetes
DOI: 10.48370/ofd/asoafm/2vlrrk
title: Peronospora trifoliorum de Bary F-0186.tif

description: :unav
DOI: 10.48370/ofd/asoafm
title: Peronospora trifoliorum de Bary, 186

description: Fungarium Micromycetes
DOI: 10.48370/ofd/dysfqd/csh4sg
title: Peronospora trifoliorum de Bary F-4310 (3).tif

description: :unav
DOI: 10.48370/ofd/dysfqd/b1jqnk
title: Peronospora trifoliorum de Bary F-4310.tif

description: :unav
DOI: 10.48370/ofd/dysfqd/uzxzpa
title: Peronospora trifoliorum de Bary F-4310 (2).tif

description: :unav
DOI: 10.48370/ofd/dysfqd/w0kmhl
title: Peronospora trifoliorum de Bary F-4310 (5).tif

description: :unav
DOI: 10.48370/ofd/dysfqd/ghwzke
title: Peronospora trifoliorum de Bary F-4310 (4).tif

description: :unav
DOI: 10.48370/ofd/dysfqd
title: Peronospora trifoliorum de Bary, 4310

description: Fungarium Micromycetes
DOI: 10.48370/ofd/xbigwk/qtxz2q
title: Peronospora trifoliorum de Bary F-0189.tif

description: :unav
DOI: 10.48370/ofd/xbigwk
title: Peronospora trifoliorum de Bary, 189

description: Fungarium Micromycetes
DOI: 10.48370/ofd/wb76ht/edyja6
title: Peronospora trifoliorum de Bary F-0812.tif

description: :unav
DOI: 10.48370/ofd/wb76ht
title: Peronospora trifoliorum de Bary, 812

description: Fungarium Micromycetes
DOI: 10.48370/ofd/is6ydh/jozqd8
title: Peronospora trivialis Gäumann F-3692.tif

description: :unav
DOI: 10.48370/ofd/is6ydh
title: Peronospora trivialis Gäumann, 3692

description: Fungarium Micromycetes
DOI: 10.48370/ofd/yd8lck/9tsfza
title: Peronospora trivialis Gäumann F-3828.jpg

description: :unav
DOI: 10.48370/ofd/yd8lck/qqx8a7
title: Peronospora trivialis Gäumann F-3828.tif

description: :unav
DOI: 10.48370/ofd/yd8lck
title: Peronospora trivialis Gäumann, 3828

description: Fungarium Micromycetes
DOI: 10.48370/ofd/xzwasu/yrcwoq
title: Peronospora trivialis Gäumann F-2270 (3).tif

description: :unav
DOI: 10.48370/ofd/xzwasu/5c2rvj
title: Peronospora trivialis Gäumann F-2270 (2).tif

description: :unav
DOI: 10.48370/ofd/xzwasu/5u8wc2
title: Peronospora trivialis Gäumann F-2270 (5).tif

description: :unav
DOI: 10.48370/ofd/xzwasu/6tcr7p
title: Peronospora trivialis Gäumann F-2270.tif

description: :unav
DOI: 10.48370/ofd/xzwasu/gen0u3
title: Peronospora trivialis Gäumann F-2270 (4).tif

description: :unav
DOI: 10.48370/ofd/xzwasu
title: Peronospora trivialis Gäumann, 2270

description: Fungarium Micromycetes
DOI: 10.48370/ofd/eig8nz/eyngjv
title: Peronospora vernalis Gäumann F-3800.tif

description: :unav
DOI: 10.48370/ofd/eig8nz
title: Peronospora vernalis Gäumann, 3800

description: Fungarium Micromycetes
DOI: 10.48370/ofd/1avr2z/wnhnfm
title: Peronospora vernalis Gäumann F-3799.tif

description: :unav
DOI: 10.48370/ofd/1avr2z
title: Peronospora vernalis Gäumann, 3799

description: Fungarium Micromycetes
DOI: 10.48370/ofd/h4xf5j/vell5u
title: Peronospora vernalis Gäumann F-2798.tif

description: :unav
DOI: 10.48370/ofd/h4xf5j
title: Peronospora vernalis Gäumann, 2798

description: Fungarium Micromycetes
DOI: 10.48370/ofd/cvmvlq/9ksxgf
title: Peronospora vernalis Gäumann F-3625.tif

description: :unav
DOI: 10.48370/ofd/cvmvlq
title: Peronospora vernalis Gäumann, 3625

description: Fungarium Micromycetes
DOI: 10.48370/ofd/hpgx6t/elui8q
title: Peronospora vernalis Gäumann F-1051 (5).tif

description: :unav
DOI: 10.48370/ofd/hpgx6t/e9tlpv
title: Peronospora vernalis Gäumann F-1051 (4).tif

description: :unav
DOI: 10.48370/ofd/hpgx6t/804zqa
title: Peronospora vernalis Gäumann F-1051 (3).tif

description: :unav
DOI: 10.48370/ofd/hpgx6t/tvoocy
title: Peronospora vernalis Gäumann F-1051.tif

description: :unav
DOI: 10.48370/ofd/hpgx6t/dzkutx
title: Peronospora vernalis Gäumann F-1051 (2).tif

description: :unav
DOI: 10.48370/ofd/hpgx6t
title: Peronospora vernalis Gäumann, 1051

description: Fungarium Micromycetes
DOI: 10.48370/ofd/lkpwvf/qdhmw6
title: Peronospora vernalis Gäumann F-1070 (5).tif

description: :unav
DOI: 10.48370/ofd/lkpwvf/2vtkeo
title: Peronospora vernalis Gäumann F-1070 (4).tif

description: :unav
DOI: 10.48370/ofd/lkpwvf/blgu98
title: Peronospora vernalis Gäumann F-1070 (2).tif

description: :unav
DOI: 10.48370/ofd/lkpwvf/inbt0a
title: Peronospora vernalis Gäumann F-1070.tif

description: :unav
DOI: 10.48370/ofd/lkpwvf/zhxeue
title: Peronospora vernalis Gäumann F-1070 (3).tif

description: :unav
DOI: 10.48370/ofd/lkpwvf
title: Peronospora vernalis Gäumann, 1070

description: Fungarium Micromycetes
DOI: 10.48370/ofd/zwizur/plwejj
title: Peronospora viciae (Berkeley) Caspary F-3515.tif

description: :unav
DOI: 10.6084/m9.figshare.19130387
title: Tabla 2. Campañas que componen la muestra

description: Table from the paper El storydoing como modelo innovador de comunicación publicitaria que favorece una mejora en la sociedad (Storydoing as an innovative model of advertising communication that favours an improvement in society). It describes the brands and their respective campaigns that make up the research sample.
DOI: 10.6084/m9.figshare.19130387.v1
title: Tabla 2. Campañas que componen la muestra

description: Table from the paper El storydoing como modelo innovador de comunicación publicitaria que favorece una mejora en la sociedad (Storydoing as an innovative model of advertising communication that favours an improvement in society). It describes the brands and their respective campaigns that make up the research sample.
DOI: 10.48370/ofd/zwizur
title: Peronospora viciae (Berkeley) Caspary, 3515

description: Fungarium Micromycetes
DOI: 10.48370/ofd/waj14g/4hv7sm
title: Peronospora viciae (Berkeley) Caspary F-2393.tif

description: :unav
DOI: 10.48370/ofd/waj14g
title: Peronospora viciae (Berkeley) Caspary, 2393

description: Fungarium Micromycetes
DOI: 10.17632/v4875253hz.1
title: Mobility, electricity, and parking data for EV infrastructure in the Amsterdam Metropolitan Area

description: The dataset combines and aggregate five data types of the Amsterdam Metropolitan Area in a polygon GIS shapefile with 79 three-digit postcode areas and a csv file, including the outcome of an origin-destination analysis. The dataset area includes 1661 residential zones (“wijken”, in the terminology used by the Dutch Central Bureau for Statistics) of the Amsterdam Metropolitan Area (AMA), and the data aggregated was originally generated between 2017 and 2019. The first dataset, in format of GIS shapefile, contains data on mobility, parking capacity, electricity demand, census data and cadaster data. The second dataset, csv format, includes the outcomes of an origin-destination analysis between the 79 three-digit postcodes areas in AMA. The two datasets provide the basis for analysis and adaptation of electric mobility in AMA.
DOI: 10.17632/drxw92dz4f.2
title: Dataset for developing event-driven IoT applications for the compilation, deployment, interaction and monitoring of smart contracts through a low-code approach

description: This dataset contains the smart contracts, called AstraZenecaVaccine and ModernVaccine, implemented in Solidity.
DOI: 10.48370/ofd/wpbequ/rhgiq2
title: Peronospora viciae (Berkeley) Caspary F-3855.tif

description: :unav
DOI: 10.17632/j8fmdwd4jp.6
title: Comparing methods for handling missing cost and outcome data in clinical trial-based cost-effectiveness analysis

description: Code for analysis of missing data
DOI: 10.48370/ofd/wpbequ/wqjxri
title: Peronospora viciae (Berkeley) Caspary F-3855 (3).tif

description: :unav
DOI: 10.48370/ofd/wpbequ/xsbjrp
title: Peronospora viciae (Berkeley) Caspary F-3855 (2).tif

description: :unav
DOI: 10.17632/xyztk3zjkv.1
title: LDHU3_08.0530

description: hypothetical protein - conserved
Leishmania donovani (HU3 strain)
DOI: 10.48370/ofd/wpbequ/bnztml
title: Peronospora viciae (Berkeley) Caspary F-3855 (4).tif

description: :unav
DOI: 10.48370/ofd/wpbequ/x4a3wi
title: Peronospora viciae (Berkeley) Caspary F-3855.jpg

description: :unav
DOI: 10.48370/ofd/wpbequ
title: Peronospora viciae (Berkeley) Caspary, 3855

description: Fungarium Micromycetes
DOI: 10.17632/pfgg68yd2y.5
title: CYP2B6 and CYP3A4 inhibition

description: Raw and relative data from chemical inhibition of CYP2B6 and CYP3A4 from Vivid bacculosomes.  

CYP2B6- and CYP3A4-transfected baculosomes from Vivid® CYP450 Blue and Red screening kits, respectively, were obtained from Life Technologies (Carlsbad, CA, USA). Potential inhibitors (and substrates) were screened as described in the Vivid® CYP450 Screening Kits User Guide. Decreased fluorescence due to chemical inhibition was measured on a Gen5 microplate reader (Synergy H1 Hybrid Reader, BioTek, Winooski, Vermont, USA) at 415/460 nm excitation/emission (CYP2B6) and 550/590 excitation/emission (CYP3A4) at automatic read intervals of 50 seconds for a 30-minute duration in kinetic assay mode. Results were exported into Microsoft Excel, where initial fluorescence was subtracted from fluorescence within the linear part of the curve to calculate change over time and averaged between replicates (n = 3-6).
DOI: 10.17632/5nzp263p5p.1
title: LDHU3_08.0520

description: signal peptidase type I
Leishmania donovani (HU3 strain)
DOI: 10.17632/n35s4z3fdd.1
title: LDHU3_08.0500

description: hypothetical protein - conserved
Leishmania donovani (HU3 strain)
DOI: 10.48370/ofd/7bq3of/xqpvdg
title: Peronospora violae de Bary ex Schroeter F-3853.tif

description: :unav
DOI: 10.48370/ofd/7bq3of
title: Peronospora violae de Bary ex Schroeter, 3853

description: Fungarium Micromycetes
DOI: 10.48370/ofd/tl42qn/sjme3g
title: Peronospora violae de Bary ex Schroeter F-3835.tif

description: :unav
DOI: 10.17632/nxzbgjy6yr.1
title: Decentralization of Information and Supply Chain Self-organization: the Resulting Effect on Network Performance in the Transitive Service Triads

description: The database covers data used in the research model in the manuscript published at Supply Chain Management: An International Journal.
DOI: 10.48370/ofd/tl42qn
title: Peronospora violae de Bary ex Schroeter, 3835

description: Fungarium Micromycetes
DOI: 10.48370/ofd/ulqh0s/bw5vn4
title: Peronospora violae de Bary ex Schroeter F-3721.tif

description: :unav
DOI: 10.48370/ofd/ulqh0s
title: Peronospora violae de Bary ex Schroeter, 3721

description: Fungarium Micromycetes
DOI: 10.48370/ofd/ggno3p/xcmwdo
title: Peronospora violae de Bary ex Schroeter F-3757.tif

description: :unav
DOI: 10.48370/ofd/ggno3p
title: Peronospora violae de Bary ex Schroeter, 3757

description: Fungarium Micromycetes
DOI: 10.17632/7n77zzn2p2.1
title: Pegbovigrastim treatment resulted in an economic benefit in a large randomized clinical trial in grazing dairy cows. Supplementary tables.

description: The objective of this study is therefore to investigate whether PEG treatment affects NPCF, milk revenues and cash outflows for feed, medical treatments, insemination and culling during a full lactation. We also explored the effect of potential interactions of PEG treatment with parity, BCS and NEFA on these outcomes.
DOI: 10.17632/ffvn36kn4f.2
title: Supplementary Figure 1-Deficient mismatch repair is detected in large to giant congenital melanocytic nevus: gaining insight into etiology and identifying potential treatments.

description: Supplementary Figure 1. WES disvovered germline mutation of MMR gene in LGCMN patients. Germline mutations of core MMR genes are colored in red. Patient 1 has a classic-type LCMN with only 3 satellite lesions. She harbored no germline mutation of MMR gene. Patient 2 was not available for WES due to the absence of normal samples. Patient 3 has a classic-type GCMN with a brest/belly pattern. Satellite lesions (<20) with a similar phenotype were discovered throughout the body. Germline mutation of the core MMR gene was not detected. Patient 4 is shown in Figure 1. Patient 5 has a classic-type GCMN with a bathing trunk pattern. Satellite lesions (20-50) with diverse phenotypes (vary in color, size, hairiness, CMN Subgroup) were discovered throughout the body. Germline mutation of MSH6 was probed, and the mutation was predicted to be deleterious. Signature of dMMR was detected in main lesions and satellite lesions of all four patients. The photos of patient 5 were taken after surgical treatments of tissue expansion. Written consents were obtained for clinical photo publication. dMMR, deficient mismatch repair; P, patient; M, main lesion; S, satellite lesion.
DOI: 10.48370/ofd/nvpuqg/gzd9op
title: Phacellium alborosellum (Desmazières) U. Braun F-1034.tif

description: :unav
DOI: 10.48370/ofd/nvpuqg
title: Phacellium alborosellum (Desmazières) U. Braun, 1034

description: Fungarium Micromycetes
DOI: 10.48370/ofd/flpy79/s6uyb6
title: Phacellium alborosellum (Desmazières) U. Braun F-2038.tif

description: :unav
DOI: 10.48370/ofd/flpy79/fop11h
title: Phacellium alborosellum (Desmazières) U. Braun F-2038 (3).tif

description: :unav
DOI: 10.48370/ofd/flpy79/gzkzsa
title: Phacellium alborosellum (Desmazières) U. Braun F-2038 (5).tif

description: :unav
DOI: 10.48370/ofd/flpy79/ci6zj6
title: Phacellium alborosellum (Desmazières) U. Braun F-2038 (2).tif

description: :unav